Skip to content
Wednesday, September 27, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • PAST MAGAZINE ISSUES
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • FEATURES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Alameda Healthcare Group strikes new 7-year pact with Siemens Healthineers
  • Egypt earns digital health recognition at Arab Hospitals Federation’s annual awards
  • Medshield Medical Scheme unveils a vision for 2024 to deliver quality healthcare across all life stages
  • Nairobi Hospital makes pioneering commitment to global sustainability and healthcare innovation
  • GHLF and Darna Center join hands to enhance healthcare equity for African women
  • Amanat names Dr. Howard Podolsky as the new Group CEO of Cambridge Medical & Rehabilitation Center
  • Applications open for the prestigious Aster Guardians Global Nursing Award 2024
  • Gates Foundation fuels GE HealthCare's AI-driven healthcare revolution with US$44 million boost
  • M-PESA Foundation constructs KES 16 million maternal health complex for Kisumu County
  • Alkem Laboratories inks antifungal drug deal with Biosergen
You are here
  • Home
  • Switzerland

Tag: Switzerland

Swiss biotech firm Rejuveron scoops US$75M in Series B round with Mubadala support

13 September 202313 September 2023

UAE – Swiss biotechnology company Rejuveron has completed a US$75M series B financing round with a significant investment from Mubadala, an investment firm headquartered in Abu Dhabi. Rejuveron is a…

Read More

Alnylam’s gene-silencing therapy could revolutionize hypertension treatment in a promising progress

11 September 202311 September 2023

USA — Alnylam Pharmaceuticals, in collaboration with Roche, is advancing rapidly with its groundbreaking RNAi therapeutic, zilebesiran, following their July 2023 partnership. Exciting news emerged as the Cambridge-based biotech unveiled…

Read More

Novartis shuffles leadership as international markets leader departs

10 September 202310 September 2023

SWITZERLAND — Novartis, in the midst of a major organizational overhaul, is facing a significant leadership change as Marie-France Tschudin, the current president of Innovative Medicine International, has chosen to…

Read More

Novartis advances spin-off of Sandoz, eyes growth in generics and biosimilars

10 September 202310 September 2023

SWITZERLAND — In a significant strategic move, Novartis has reaffirmed its commitment to the spin-off of its generics and biosimilars division, Sandoz. The progression of this initiative hinges on obtaining…

Read More

Nestlé sells peanut-allergy medicine business to Stallergenes Greer

5 September 20235 September 2023

SWITZERLAND — Nestlé has divested its peanut-allergy medicine business, Palforzia, to Swiss biopharmaceutical company Stallergenes Greer. This decision follows Nestlé’s announcement last year regarding a comprehensive review of Palforzia’s future…

Read More

Long-term efficacy of Novartis’ siRNA therapy in LDL-C reduction unveiled in three-year follow-up trial

29 August 202329 August 2023

SWITZERLAND —In a significant stride towards combatting cardiovascular disease, a recent three-year follow-up trial has underscored the unwavering efficacy of Leqvio (inclisiran) when used alongside statin therapy. The groundbreaking treatment…

Read More

WHO and G20 launch global initiative on digital health to drive transformation

22 August 202322 August 2023

SWITZERLAND — The collaboration between the World Health Organization (WHO) and the G20 India presidency has given birth to the Global Initiative on Digital Health (GIDH). This announcement was made…

Read More

WHO Global Summit commits to advancing evidence-based traditional and integrative medicine for health and well-being

22 August 202322 August 2023

SWITZERLAND —The inaugural World Health Organization (WHO) Global Summit on Traditional Medicine 2023 has concluded with a resounding commitment from partner organizations and stakeholders to harness the potential of evidence-based…

Read More

WHO classifies EG.5 Coronavirus variant as “Variant of Interest”

10 August 202310 August 2023

SWITZERLAND — In a critical move, the World Health Organization (WHO) has designated the EG.5 coronavirus strain circulating in the United States and China as a “variant of interest.” Despite…

Read More

Vabysmo’s soaring success and Polivy’s blockbuster ambitions boost Roche’s sales amid COVID-19 challenges

28 July 202328 July 2023

SWITZERLAND— In a year marked by unprecedented challenges in the pharmaceutical industry, Roche, the Swiss drugs and diagnostics giant, showcased its resilience and innovative prowess. The company’s first-half core operating…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

UPCOMING EVENTS

Africa Health Expo

March 7-9, 2024

Visa Oshwal Centre, Nairobi, Kenya

Africa Hospitals & Wellness Expo

March 7-9, 2024

Visa Oshwal Centre, Nairobi, Kenya

LATEST NEWS

  • Alameda Healthcare Group strikes new 7-year pact with Siemens Healthineers
  • Egypt earns digital health recognition at Arab Hospitals Federation’s annual awards
  • Medshield Medical Scheme unveils a vision for 2024 to deliver quality healthcare across all life stages
  • Nairobi Hospital makes pioneering commitment to global sustainability and healthcare innovation
  • GHLF and Darna Center join hands to enhance healthcare equity for African women

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Johnson & Johnson Kenya Malaria Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Partnerships Pfizer Pharmaceuticals Public Health Roche Rwanda Saudi Arabia Science & Technology South Africa Switzerland Tanzania technology UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

QUICK LINKS

Advertise 

Contact the Publisher

About the Magazine

Press Releases

Subscribe to E-Newsletter

RELATED PUBLICATIONS

Food Business Africa

Food Safety Africa

Milling Middle East & Africa

Sustainable Packaging Africa

CEO Business Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.